Weekly round-up #250
Our 250th Weekly Round-up.
Our first First Weekly Roundup was published on 14 August 2017 - 5 years, 4 months, 28 days ago. Take a trip down memory lane and have a look through our archive of Weekly round-ups.
VALIDATE Seminar - One Health and a retrospective study of laboratory-based melioidosis surveillance in Thailand
It is well-recognized that melioidosis is endemic in most parts of Thailand. However, the prevalence of melioidosis in humans and animals, and the occurrence of its pathogen, Burkholderia pseudomallei, in the natural environment of southern Thailand has not been updated for a long time. In this seminar, Dr Apichai Tuanyok will discuss his team’s “One Health” approach and multidisciplinary research to investigate the epidemiology of melioidosis in southern Thailand.
The seminar will take place 22 February 2023 at 15:00 GMT on Zoom. Register online: www.validate-network.org/event/one-health-thailand
- MRC New Unit Funding Opportunity - funding to tackle complex and interdisciplinary health challenges - deadline 23 February 2023
- EPSRC Centres for Doctoral Training – Supports the next generation of internationally recognised researchers addressing key interdisciplinary needs, aligned global priorities across academia and industry - deadline 7 March 2023
- NIH Cooperative Centers on Human Immunology – Funding to support mechanistic and hypothesis-testing studies to discover mechanics sgoverning function of the human immune system - deadline 7 April 2023
You can find a list of all relevant external funding we've spotted for our members on our external funding page.
Training Opportunities and Events:
- International Conference on Clinical Immunology and Immunotoxicology 2023, New York, USA, 28 January 2023
- SIGNET 2023, Perth, UK, 8 February 2024
- Research Assistant - Immunology, NDM Experimental Medicine , University if Oxford, UK, Deadline 13 January 2023
Other relevant career opportunities are on our jobs page.
- M. tuberculosis antigen-responsive IL17+ CD4 T cells are disproportionately spared in ART-suppressed HIV, VALIDATE Associate Paul Ogongo et al, in bioRxiv
- T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection, VALIDATE Associate Munyaradzi Musvosvi et al, in Nature Medicine
- Functional characterization and immunogenicity of a novel vaccine candidate against tick-borne encephalitis virus based on Leishmania-derived virus-like particles, M et al, in Antiviral Research
Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.
Highlights on Twitter this week:
GenomeWeb reported on recent sequencing studies that could lead to a new TB vaccine, Hindu Business Lin Reported on the next generation of TB vaccines, and we shared a Nature report about Finding antigens for TB vaccines. Economic Times India reported on a new BCG clinical trial, SATVI celebrated a new study identifying TB vaccine candidates, and EDCTP shared a video discussion with Thomas Nyirenda about TB being Africa’s deadliest disease. Nature announced they will support authors in 70 LMICs to make their publications open access, Nature Careers also reviewed the challenges faced by the global scientific workforce of 2022, discussed the return of International Students to the US after Trump and the Guardian reported on imported macaques carrying melioidosis into the US. Keep up to date with all the relevant news and opportunities by following @NetworkVALIDATE on Twitter.
Published: 11 January 2023
